Vapotherm Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Vapotherm Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6553
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vapotherm Inc (Vapotherm) is a medical device company that develops and manufactures advanced non-invasive respiratory care devices. The company offers products such as Precision Flow products and accessories, medical-grade vapor, disposable patient circuit, nitric oxide disposable patient circuit, nasal cannulas, tracheostomy adapter, Aerogen adapter, and Vapotherm transfer unit. Its products are used in areas such as adult intensive care unit, neonatal intensive care unit, pediatric intensive care unit, acute care and palliative care for infant and adult patients. The company, though its Hi-VNI Technology platform, provides treatment for respiratory distress including hypoxemia, hypercapnia and dyspnea. The company markets its products in the Americas, Europe, Middle East, Africa, Asia and Australia. Vapotherm is headquartered in Exeter, New Hampshire, the US.

Vapotherm Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vapotherm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vapotherm Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vapotherm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vapotherm Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Vapotherm Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Vapotherm Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Vapotherm Raises USD10 Million in Venture Financing 11
Vapotherm Raises USD20 Million in Venture Financing 12
Vapotherm Raises USD15 Million in Venture Financing 14
Vapotherm Raises USD20 Million in Series C Financing 16
Vapotherm Raises US$24 Million In Series B Financing 18
Vapotherm Raises US$29 Million In Venture Financing 20
Partnerships 22
Praxair Enters Into Co-Marketing Agreement With Vapotherm For Heliox Delivery System 22
Vapotherm Inc – Key Competitors 23
Vapotherm Inc – Key Employees 24
Vapotherm Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Corporate Communications 26
Oct 18, 2017: Vapotherm Appoints Marina Hahn and Elizabeth Weatherman to the Company’s Board of Directors 26
Product News 27
Jul 18, 2018: Clinical study describes high velocity nasal insufflation as a viable alternative to NiPPV 27
Jan 29, 2018: Vapotherm Shows Noninferiority to NIPPV for Undifferentiated Respiratory Distress in the Emergency Department 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Vapotherm Inc, Medical Equipment, Key Facts 2
Vapotherm Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Vapotherm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vapotherm Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vapotherm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vapotherm Inc, Deals By Market, 2012 to YTD 2018 8
Vapotherm Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Vapotherm Raises USD10 Million in Venture Financing 11
Vapotherm Raises USD20 Million in Venture Financing 12
Vapotherm Raises USD15 Million in Venture Financing 14
Vapotherm Raises USD20 Million in Series C Financing 16
Vapotherm Raises US$24 Million In Series B Financing 18
Vapotherm Raises US$29 Million In Venture Financing 20
Praxair Enters Into Co-Marketing Agreement With Vapotherm For Heliox Delivery System 22
Vapotherm Inc, Key Competitors 23
Vapotherm Inc, Key Employees 24
Vapotherm Inc, Other Locations 25

List of Figures
Vapotherm Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Vapotherm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Vapotherm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Vapotherm Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Vapotherm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vapotherm Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Vapotherm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vapotherm Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Vapotherm Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Al Arrab Contracting Company:企業の戦略的SWOT分析
    Al Arrab Contracting Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • SDL plc (SDL):企業の財務・戦略的SWOT分析
    Summary SDL Plc (SDL) is a technology solution provider that offers language translation technology, services, and content management services. The company’s products include live content architect, live content create, media manager, idiom world server, campaign analytics, email manager, language w …
  • Concho Resources Inc (CXO):石油・ガス:M&Aディール及び事業提携情報
    Summary Concho Resources Inc (Concho) is an oil and gas company that acquires, develops and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin region of Southeast New Mexico and West Texas, an onshore oil and natural gas basin in the US. Co …
  • Co-Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Pro-Pac Packaging Ltd (PPG):企業の財務・戦略的SWOT分析
    Pro-Pac Packaging Ltd (PPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Beijing Enterprises Holdings Ltd:企業の戦略・SWOT・財務情報
    Beijing Enterprises Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Beijing Enterprises Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Engie SA (ENGI)-エネルギー分野:企業M&A・提携分析
    Summary Engie S.A. (Engie), formerly GDF Suez S.A., is an electric utility, which generates and distributes electricity and natural gas. It generates electricity using various sources including hydro, wind, solar, biomass, geothermal, nuclear, coal and fuel oil. The company supplies, distributes, tr …
  • Conair Corporation:企業の戦略・SWOT・財務分析
    Conair Corporation - Strategy, SWOT and Corporate Finance Report Summary Conair Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (FDZJ), a subsidiary of Shanghai Pharmaceutical Co Ltd, is a bio-pharmaceutical company that develops, manufactures and markets genetic engineering drugs. The company offers bio-pharmaceutical products in the field of genetic engineering, p …
  • Aramark (ARMK):企業の財務・戦略的SWOT分析
    Aramark (ARMK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Zh International Holdings Ltd
    Zh International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zh International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sangamo Therapeutics Inc (SGMO)-製薬・医療分野:企業M&A・提携分析
    Summary Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biopharmaceutical company which focuses on the research and development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation and therapeutic genome editing. The company is …
  • National Health Insurance Company – Daman PJSC:企業の戦略・SWOT・財務分析
    National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report Summary National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Congenica Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers research and experimental development on biotechnology. The company’s technology SAPIENTIA, is used to personalize patient care through accurate diagnoses, support clinical trials, and drug development. It offers services such …
  • Groupe Lactalis S.A.:企業の戦略・SWOT・財務情報
    Groupe Lactalis S.A. - Strategy, SWOT and Corporate Finance Report Summary Groupe Lactalis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Merge Healthcare Incorporated:企業のM&A・事業提携・投資動向
    Merge Healthcare Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merge Healthcare Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • First Electric Cooperative Corporation:企業の発電所・SWOT分析2018
    First Electric Cooperative Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • BioMedomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube base …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆